Aelis Farma: Combined General Meeting of May 24, 2023: Availability of Preparatory Documents and Participation and Voting Procedures

Aelis Farma (ISIN: FR0014007ZB4 Ticker: AELIS, PEA-PME eligible) (Paris: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases, informs

Related Keywords

United States ,Spain ,Paris ,France General ,France ,Vincenzo Piazza ,Magendie Neurocenter ,Daelis Farma ,Arthur Rouill ,Twitter ,Linkedin ,Combined General Meeting ,Lafaurie De Mondabon ,General Meeting ,Investors General ,Commercial Code ,Signaling Specific ,Pier Vincenzo Piazza ,Down Syndrome ,Euronext Paris ,Universal Registration Document ,Des March ,Saelis ,Sarma ,Combined ,Eneral ,Meeting ,023 ,Availability ,Preparatory ,Documents ,Participation ,Voting ,Procedures ,